HBx enhanced the cancer stemness of HCC cells by promoting Nix-dependent mitophagy-mediated glycolysis metabolism reprogramming, indicating that Nix might be a potential therapeutic target for HCC.83 This evidence concerns the gene BNIP3L and hepatocellular carcinoma.